Back to search

Article

Developmental reversion underlies resistance to immune checkpoint blockade in kidney cancer

2026-08-06

Abstract excerpt

Despite the clinical success of immune checkpoint inhibitors (ICIs) in the management of advanced clear cell renal cell carcinoma (ccRCC), many tumors develop acquired resistance, presumed to arise from a refractory subpopulation of persister cancer cells. Previous studies have provided insights into tumor microenvironment-specific drivers of ICI resistance in ccRCC. However, the extent to which ccRCC cells underg...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
037b13ad-9bd8-5d23-a0cc-011d18881a4a
DOI
10.64898/2026.08.05.743137
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Developmental reversion underlies resistance to immune checkpoint blockade in kidney cancerDOI 10.64898/2026.08.05.743137
Select a neighboring publication to make it the new centre.